Annual CFF
$8.60 M
-$1.79 M-17.19%
December 31, 2022
Summary
- As of February 10, 2025, HTGM annual cash flow from financing activities is $8.60 million, with the most recent change of -$1.79 million (-17.19%) on December 31, 2022.
- During the last 3 years, HTGM annual CFF has fallen by -$10.79 million (-55.63%).
Performance
HTGM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFF
-$1.31 M
-$9.01 M-117.01%
March 31, 2023
Summary
- As of February 10, 2025, HTGM quarterly cash flow from financing activities is -$1.31 million, with the most recent change of -$9.01 million (-117.01%) on March 31, 2023.
- Over the past year, HTGM quarterly CFF has dropped by -$6.88 million (-123.54%).
Performance
HTGM Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFF
$1.73 M
-$6.88 M-79.91%
March 31, 2023
Summary
- As of February 10, 2025, HTGM TTM cash flow from financing activities is $1.73 million, with the most recent change of -$6.88 million (-79.91%) on March 31, 2023.
- Over the past year, HTGM TTM CFF has dropped by -$7.70 million (-81.67%).
Performance
HTGM TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
HTGM Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -17.2% | -123.5% | -81.7% |
| 3 y3 years | -55.6% | -147.4% | -92.4% |
| 5 y5 years | -45.4% | -103.4% | -91.1% |
HTGM Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -17.2% | at low | -117.0% | +134.9% | -83.4% | -49.6% |
| 5 y | 5-year | -55.6% | at low | -117.0% | +134.9% | -93.1% | -49.6% |
| alltime | all time | -83.2% | -76.5% | -102.7% | +134.9% | -97.1% | -371.1% |
HTG Molecular Diagnostics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$1.31 M(-117.0%) | $1.73 M(-79.9%) |
| Dec 2022 | $8.60 M(-17.2%) | $7.70 M(-350.2%) | $8.60 M(+887.8%) |
| Sep 2022 | - | -$3.08 M(+94.3%) | $871.10 K(-79.1%) |
| Jun 2022 | - | -$1.58 M(-128.5%) | $4.17 M(-55.8%) |
| Mar 2022 | - | $5.57 M(<-9900.0%) | $9.43 M(-9.3%) |
| Dec 2021 | $10.39 M(+14.8%) | -$33.50 K(-115.1%) | $10.39 M(-14.9%) |
| Sep 2021 | - | $222.20 K(-94.0%) | $12.21 M(-13.4%) |
| Jun 2021 | - | $3.68 M(-43.7%) | $14.10 M(+10.0%) |
| Mar 2021 | - | $6.53 M(+265.2%) | $12.82 M(+41.6%) |
| Dec 2020 | $9.05 M(-53.3%) | $1.79 M(-15.4%) | $9.05 M(+38.1%) |
| Sep 2020 | - | $2.11 M(-11.5%) | $6.55 M(-74.0%) |
| Jun 2020 | - | $2.39 M(-13.5%) | $25.18 M(+11.3%) |
| Mar 2020 | - | $2.76 M(-490.0%) | $22.62 M(+16.6%) |
| Dec 2019 | $19.39 M(-49.1%) | -$707.90 K(-103.4%) | $19.39 M(-2.9%) |
| Sep 2019 | - | $20.74 M(<-9900.0%) | $19.98 M(-2250.9%) |
| Jun 2019 | - | -$171.90 K(-63.1%) | -$928.80 K(-17.6%) |
| Mar 2019 | - | -$465.80 K(+282.1%) | -$1.13 M(-103.0%) |
| Dec 2018 | $38.13 M | -$121.90 K(-28.0%) | $38.13 M(-10.3%) |
| Sep 2018 | - | -$169.20 K(-54.4%) | $42.49 M(-0.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2018 | - | -$370.80 K(-101.0%) | $42.84 M(-23.9%) |
| Mar 2018 | - | $38.79 M(+814.5%) | $56.28 M(+257.3%) |
| Dec 2017 | $15.75 M(+677.7%) | $4.24 M(+2306.0%) | $15.75 M(+34.0%) |
| Sep 2017 | - | $176.30 K(-98.7%) | $11.75 M(+18.6%) |
| Jun 2017 | - | $13.07 M(-851.9%) | $9.91 M(-311.5%) |
| Mar 2017 | - | -$1.74 M(-816.4%) | -$4.69 M(-331.3%) |
| Dec 2016 | $2.03 M(-96.0%) | $242.70 K(-114.6%) | $2.03 M(+12.8%) |
| Sep 2016 | - | -$1.67 M(+9.5%) | $1.80 M(-48.4%) |
| Jun 2016 | - | -$1.52 M(-130.6%) | $3.48 M(-93.5%) |
| Mar 2016 | - | $4.97 M(>+9900.0%) | $53.37 M(+4.4%) |
| Dec 2015 | $51.11 M(+226.5%) | $13.50 K(-25.8%) | $51.11 M(+2.1%) |
| Sep 2015 | - | $18.20 K(-100.0%) | $50.04 M(-14.9%) |
| Jun 2015 | - | $48.37 M(+1685.2%) | $58.82 M(+476.9%) |
| Mar 2015 | - | $2.71 M(-356.6%) | $10.20 M(-34.9%) |
| Dec 2014 | $15.65 M(+120.5%) | -$1.06 M(-112.0%) | $15.65 M(-6.3%) |
| Sep 2014 | - | $8.80 M(-3546.1%) | $16.71 M(+111.2%) |
| Jun 2014 | - | -$255.30 K(-103.1%) | $7.91 M(-3.1%) |
| Mar 2014 | - | $8.17 M | $8.17 M |
| Dec 2013 | $7.10 M(-1.0%) | - | - |
| Dec 2012 | $7.17 M | - | - |
FAQ
- What is HTG Molecular Diagnostics annual cash flow from financing activities?
- What is the all time high annual CFF for HTG Molecular Diagnostics?
- What is HTG Molecular Diagnostics annual CFF year-on-year change?
- What is HTG Molecular Diagnostics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for HTG Molecular Diagnostics?
- What is HTG Molecular Diagnostics quarterly CFF year-on-year change?
- What is HTG Molecular Diagnostics TTM cash flow from financing activities?
- What is the all time high TTM CFF for HTG Molecular Diagnostics?
- What is HTG Molecular Diagnostics TTM CFF year-on-year change?
What is HTG Molecular Diagnostics annual cash flow from financing activities?
The current annual CFF of HTGM is $8.60 M
What is the all time high annual CFF for HTG Molecular Diagnostics?
HTG Molecular Diagnostics all-time high annual cash flow from financing activities is $51.11 M
What is HTG Molecular Diagnostics annual CFF year-on-year change?
Over the past year, HTGM annual cash flow from financing activities has changed by -$1.79 M (-17.19%)
What is HTG Molecular Diagnostics quarterly cash flow from financing activities?
The current quarterly CFF of HTGM is -$1.31 M
What is the all time high quarterly CFF for HTG Molecular Diagnostics?
HTG Molecular Diagnostics all-time high quarterly cash flow from financing activities is $48.37 M
What is HTG Molecular Diagnostics quarterly CFF year-on-year change?
Over the past year, HTGM quarterly cash flow from financing activities has changed by -$6.88 M (-123.54%)
What is HTG Molecular Diagnostics TTM cash flow from financing activities?
The current TTM CFF of HTGM is $1.73 M
What is the all time high TTM CFF for HTG Molecular Diagnostics?
HTG Molecular Diagnostics all-time high TTM cash flow from financing activities is $58.82 M
What is HTG Molecular Diagnostics TTM CFF year-on-year change?
Over the past year, HTGM TTM cash flow from financing activities has changed by -$7.70 M (-81.67%)